Xiaobo Bo

447 total citations
24 papers, 278 citations indexed

About

Xiaobo Bo is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Xiaobo Bo has authored 24 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiaobo Bo's work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Gallbladder and Bile Duct Disorders (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaobo Bo is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Gallbladder and Bile Duct Disorders (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaobo Bo collaborates with scholars based in China. Xiaobo Bo's co-authors include Yueqi Wang, Houbao Liu, Tao Suo, Jie Wang, Xiaoling Ni, Changcheng Wang, Sheng Shen, Hui Wang, Jingquan Li and Jiejie Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgical Oncology and Oncotarget.

In The Last Decade

Xiaobo Bo

23 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo Bo China 11 138 124 99 88 80 24 278
Yueyun Chen China 9 64 0.5× 170 1.4× 108 1.1× 71 0.8× 57 0.7× 27 301
Arnab Basu United States 9 87 0.6× 165 1.3× 126 1.3× 62 0.7× 58 0.7× 49 284
Audrey E. Kam United States 7 93 0.7× 161 1.3× 102 1.0× 64 0.7× 70 0.9× 17 247
Yingsheng Wen China 12 72 0.5× 145 1.2× 155 1.6× 94 1.1× 107 1.3× 27 323
Shinobu Tomochika Japan 9 108 0.8× 125 1.0× 70 0.7× 56 0.6× 72 0.9× 39 285
Antonio Santaniello Italy 7 89 0.6× 122 1.0× 102 1.0× 77 0.9× 61 0.8× 14 242
Liubin Shi China 13 197 1.4× 118 1.0× 146 1.5× 122 1.4× 109 1.4× 24 383
Shibo Bian China 11 119 0.9× 93 0.8× 131 1.3× 106 1.2× 42 0.5× 28 333
Taro Isobe Japan 10 147 1.1× 139 1.1× 195 2.0× 72 0.8× 71 0.9× 31 345
Seung Tae Kim South Korea 9 89 0.6× 186 1.5× 169 1.7× 67 0.8× 62 0.8× 16 322

Countries citing papers authored by Xiaobo Bo

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Bo more than expected).

Fields of papers citing papers by Xiaobo Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Bo. The network helps show where Xiaobo Bo may publish in the future.

Co-authorship network of co-authors of Xiaobo Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Bo. A scholar is included among the top collaborators of Xiaobo Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Bo. Xiaobo Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yueqi, Shengli Li, Xiaobo Bo, et al.. (2024). CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma. Clinical and Translational Medicine. 14(10). e70060–e70060. 5 indexed citations
2.
Fan, Kun, Jiwen Wang, Xiaojian Ni, et al.. (2023). MUC16 C terminal fragment activates YAP1 through Src signaling to promote gallbladder cancer growth. SHILAP Revista de lepidopterología. 2(4).
3.
Wang, Changcheng, Jie Wang, Shulong Zhang, et al.. (2022). ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer. Frontiers in Oncology. 12. 787897–787897. 4 indexed citations
4.
5.
Wang, Changcheng, Jie Wang, Xiaobo Bo, et al.. (2021). Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients. Frontiers in Oncology. 11. 696714–696714. 3 indexed citations
6.
7.
Chen, Peizhan, Yueqi Wang, Jingquan Li, et al.. (2021). Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single‐cell RNA sequencing. SHILAP Revista de lepidopterología. 11(6). e462–e462. 48 indexed citations
8.
Bo, Xiaobo, Jie Wang, Changcheng Wang, et al.. (2020). High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer. Cancer Science. 111(3). 817–825. 10 indexed citations
9.
Bo, Xiaobo, Jie Wang, Zhihui Gao, et al.. (2020). 3D laparoscopic common bile duct exploration versus 2D in choledocholithiasis patients: a propensity score analysis. Surgical Endoscopy. 35(2). 819–825. 3 indexed citations
10.
Wang, Jie, Xiaobo Bo, Min Li, et al.. (2020). Prediction Efficacy for Clinical Outcome of Prognostic Nutritional Index in Patients with Resectable Biliary Tract Cancer Depends on Sex and Obstructive Jaundice Status. Annals of Surgical Oncology. 28(1). 430–438. 11 indexed citations
11.
Wang, Jie, Xiaobo Bo, Zhihui Gao, et al.. (2019). Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010‐2016. Cancer Medicine. 9(4). 1335–1348. 10 indexed citations
12.
Bo, Xiaobo, Erbao Chen, Jie Wang, et al.. (2019). Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. Annals of Translational Medicine. 7(22). 627–627. 25 indexed citations
13.
Wang, Jie, Xiaobo Bo, Yueqi Wang, & Houbao Liu. (2019). Modified Staging Classification of Gallbladder Carcinoma on the Basis of the 8th Edition of American Joint Commission on Cancer (AJCC) Staging System. HPB. 21. S266–S266. 1 indexed citations
14.
Wang, Jie, Xiaobo Bo, Changcheng Wang, et al.. (2019). Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer. Cancer Science. 111(1). 219–228. 12 indexed citations
15.
Wang, Jie, Xiaobo Bo, Xiao Shi, et al.. (2019). Modified staging classification of gallbladder carcinoma on the basis of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system. European Journal of Surgical Oncology. 46(4). 527–533. 10 indexed citations
16.
Wang, Jie, Xiaobo Bo, Tao Suo, et al.. (2018). Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer. Cancer Science. 109(7). 2266–2274. 24 indexed citations
17.
Bo, Xiaobo, Jie Wang, Tao Suo, et al.. (2018). Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients. BMC Cancer. 18(1). 313–313. 17 indexed citations
18.
Bo, Xiaobo, et al.. (2018). The regulation and function of microRNA-377/RASSF8 signaling axis in gastric cancer. Oncology Letters. 15(3). 3630–3638. 6 indexed citations
19.
Wang, Yueqi, Xiaobo Bo, Yaojie Wang, et al.. (2017). Laparoscopic surgery for choledocholithiasis concomitant with calculus of the left intrahepatic duct or abdominal adhesions. Surgical Endoscopy. 31(11). 4780–4789. 7 indexed citations
20.
Chen, Yusheng, et al.. (2015). Outcomes of Laparoscopic Abdominoperineal Resection in Low Rectal Cancer Using Different Pelvic Drainages. Asian Pacific Journal of Cancer Prevention. 16(1). 153–155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by Arnab Basu Breakdown of academic impact, for papers by Audrey E. Kam Breakdown of academic impact, for papers by Yingsheng Wen Breakdown of academic impact, for papers by Shinobu Tomochika Breakdown of academic impact, for papers by Antonio Santaniello Breakdown of academic impact, for papers by Liubin Shi Breakdown of academic impact, for papers by Shibo Bian Breakdown of academic impact, for papers by Taro Isobe Breakdown of academic impact, for papers by Seung Tae Kim
Rankless by CCL
2026